SGMT Stock Analysis: Buy, Sell, or Hold?
SGMT - Sagimet Biosciences Inc. Series A Common Stock
$6.23
0.56 (9.88%)
▲
5d:
+3.32%
30d:
+5.24%
90d:
-23.46%
BUY
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 11, 2026
Get Alerted When SGMT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SGMT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SGMT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SGMT is currently trading at $6.23, which is considered oversold relative to its 30-day fair value range of $5.71 to $6.28.
Technical Outlook: Technically, SGMT is in a downtrend. Immediate support is located at $5.01, while resistance sits at $6.60. The stock is showing strong short-term momentum, up 9.9% recently.
Market Sentiment: SGMT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.62 (+311.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SGMT is in a downtrend. Immediate support is located at $5.01, while resistance sits at $6.60. The stock is showing strong short-term momentum, up 9.9% recently.
Market Sentiment: SGMT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.62 (+311.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$5.71 -
$6.28
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.9%)
- BULLISH: Trading 311.3% below Wall St target ($25.62)
Fair Price Analysis
30-Day Fair Range
$5.71 -
$6.28
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$5.02
Resistance Level
$6.60
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.26
Wall Street Target
$25.63
(+311.3%)
Last updated: February 02, 2026 10:03 PM ET
Data refreshes hourly during market hours. Next update: 11:03 PM
Data refreshes hourly during market hours. Next update: 11:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGMT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 61 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 60 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 58 HOLD |
